REGN
Regeneron Pharmaceuticals Inc
Price:  
778.50 
USD
Volume:  
1,249,739.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron WACC - Weighted Average Cost of Capital

The WACC of Regeneron Pharmaceuticals Inc (REGN) is 8.5%.

The Cost of Equity of Regeneron Pharmaceuticals Inc (REGN) is 8.60%.
The Cost of Debt of Regeneron Pharmaceuticals Inc (REGN) is 4.25%.

Range Selected
Cost of equity 7.50% - 9.70% 8.60%
Tax rate 9.50% - 11.60% 10.55%
Cost of debt 4.00% - 4.50% 4.25%
WACC 7.4% - 9.6% 8.5%
WACC

Regeneron WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.79 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 9.70%
Tax rate 9.50% 11.60%
Debt/Equity ratio 0.03 0.03
Cost of debt 4.00% 4.50%
After-tax WACC 7.4% 9.6%
Selected WACC 8.5%